Selected article for: "varicella zoster virus and zoster virus"

Author: Ishiguro, Takashi; Kobayashi, Yasuhito; Uozumi, Ryuji; Takata, Naomi; Takaku, Yotaro; Kagiyama, Naho; Kanauchi, Tetsu; Shimizu, Yoshihiko; Takayanagi, Noboru
Title: Viral Pneumonia Requiring Differentiation from Acute and Progressive Diffuse Interstitial Lung Diseases
  • Document date: 2019_12_15
  • ID: 6zzunn00_35
    Snippet: Most of the patients in the present study received corticosteroid therapy because they were misdiagnosed as having ILDs. The use of corticosteroids for the treatment of viral pneumonia is controversial. Corticosteroids have been reported to be ineffective in the treatment of RSV in children (28) . However, some data suggest favorable effects on varicella-zoster virus (in combination with acyclovir) and hantavirus (29) and in influenza-associated .....
    Document: Most of the patients in the present study received corticosteroid therapy because they were misdiagnosed as having ILDs. The use of corticosteroids for the treatment of viral pneumonia is controversial. Corticosteroids have been reported to be ineffective in the treatment of RSV in children (28) . However, some data suggest favorable effects on varicella-zoster virus (in combination with acyclovir) and hantavirus (29) and in influenza-associated pneumonia in some clinical settings (30, 31) . In our 13 patients with influenza-associated pneumonia, corticosteroids were administered without NIs to 6 patients, and were effective. Among the patients with viral pneumonia due to non-influenza viruses, corticosteroids were administered to 21 patients, 1 of whom did not survive; however, they were effective in the other 20 patients (95.2%). The significance of corticosteroid therapy for viral pneumonia should be addressed in future studies.

    Search related documents:
    Co phrase search for related documents
    • acyclovir combination and viral pneumonia: 1
    • acyclovir combination and viral pneumonia treatment: 1
    • clinical setting and corticosteroid therapy: 1, 2
    • clinical setting and future study: 1, 2, 3
    • clinical setting and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
    • clinical setting and present study patient: 1, 2
    • clinical setting and RSV treatment: 1, 2
    • clinical setting and viral pneumonia: 1, 2, 3, 4, 5, 6, 7, 8
    • corticosteroid therapy and favorable effect: 1
    • corticosteroid therapy and non influenza virus: 1
    • corticosteroid therapy and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • corticosteroid therapy and RSV treatment: 1
    • corticosteroid therapy and viral pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • corticosteroid therapy and viral pneumonia corticosteroid therapy: 1, 2
    • corticosteroid therapy and viral pneumonia treatment: 1, 2, 3, 4
    • corticosteroid therapy receive and viral pneumonia: 1, 2
    • corticosteroid therapy receive and viral pneumonia corticosteroid therapy: 1
    • corticosteroid therapy receive and viral pneumonia treatment: 1
    • favorable effect and future study: 1